On December 5, 2022, SonoThera, Inc. closed the transaction. The round of funding led by Arch Venture Partners, L.P.. The transaction also involved participation from IIF Management Company, LLC, Johnson & Johnson Innovation - JJDC, Inc., Vertex Ventures HC, Medical Excellence Capital, LLC, Eli Lilly and Company, Alexandria Venture Investments, LLC, Lifespan Investments B.v., Formic Ventures, Foothill Ventures, LLC and Wilson Sonsini Goodrich & Rosati, P.C.